Fibator 5 Tablet is a combination medication containing Atorvastatin 5mg and Fenofibrate 145mg, primarily used to manage dyslipidemia and reduce the risk of cardiovascular disease. Atorvastatin, a statin, works by inhibiting HMG-CoA reductase, an enzyme involved in cholesterol synthesis, thereby lowering low-density lipoprotein (LDL) cholesterol and total cholesterol levels. Fenofibrate, a fibric acid derivative, helps reduce triglycerides and increase high-density lipoprotein (HDL) cholesterol by activating peroxisome proliferator-activated receptors (PPARs), which enhance lipid metabolism. This dual action makes Fibator 5 effective in patients with mixed dyslipidemia who require both LDL cholesterol reduction and triglyceride control. It is typically prescribed alongside lifestyle modifications such as diet, exercise, and weight management. Common side effects may include gastrointestinal discomfort, muscle pain, or elevated liver enzymes, and regular monitoring of liver function and muscle health is recommended during therapy. Fibator 5 should be used cautiously in patients with liver or kidney impairment and is contraindicated in pregnancy and breastfeeding. By addressing multiple lipid abnormalities simultaneously, Fibator 5 Tablet offers a comprehensive approach to lipid management, helping to lower the risk of atherosclerosis, heart attack, and stroke.